DAVID YUNA: Open Payments
NPI 1164958583 · LATROBE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 69 payments from 11 companies in 2025. Trend: 2023 $221 · 2024 $826 · 2025 $1,360
Food & beverage: $1,360
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $292 |
| ABBVIE INC. | 20 | $264 |
| Vanda Pharmaceuticals Inc. | 9 | $228 |
| Neurocrine BioSciences, Inc. | 12 | $210 |
| Janssen Pharmaceuticals, Inc | 5 | $96 |
| Supernus Pharmaceuticals, Inc. | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Lundbeck LLC | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: VRAYLAR, INGREZZA, ARISTADA, FANAPT, LYBALVI, HETLIOZ, Qelbree, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
